...
首页> 外文期刊>Journal of the Royal Naval Medical Service >Contraception in sea-going service personnel
【24h】

Contraception in sea-going service personnel

机译:海上服务人员的避孕

获取原文
获取原文并翻译 | 示例
           

摘要

The right to make an informed choice about contraception should be afforded to every individual serving within the United Kingdom (UK) Armed Forces. This article looks at the responsibilities and approach that healthcare professionals should take within a Primary Care setting, summarises the common contraceptive options available, discusses the associated advantages and disadvantages of each technique, and considers operational factors in a military environment that combine to influence the final contraceptive choice an individual makes. Case Study A 19-year old Able Rate joined the Royal Navy (RN) and at her joining medical it was noted that she had been on Microgynon? combined oral contraceptive pill for approximately three years. During this time, her menstrual periods remained light; she never experienced adverse effects, demonstrated good compliance, and was happy to remain on this contraceptive regimen. Over the course of the next eighteen months, she was reviewed by a number of Medical Officers and Civilian Medical Practitioners on a quarterly basis, with Microgynon? re-prescribed on each occasion. The appropriate Defence Medical Information Capability Programme (DMICP) template was used, with weight, smoking status, compliance and any issues or comments documented accordingly. In December 2010, a discussion regarding long-acting reversible contraception (LARC) was documented for the first time. The patient agreed to give LARC some thought and a review appointment was made for one month. She was subsequently started on the progesto gen-only pill Cerazette? . It was noted by the consulting doctor that both the patient's mother and grandmother had a positive history of cerebrovascular events and the combined oral contraceptive pill was discontinued. Upon review at two months, the patient reported that she was content on Cerazette? and wished to continue with this medication. She was amenorrhoeic, highly compliant, had given up smoking and her weight and blood pressure were stable. However, due to supply issues, it was explained that Cerazette? was no longer a viable option for her. She had no plans to start a family, and was keen to investigate other contraceptive options.
机译:联合王国(UK)武装部队中服役的每个人都应有权就避孕采取知情选择的权利。本文探讨了医疗保健专业人员在基层医疗机构中应承担的责任和方法,总结了可用的常见避孕方法,讨论了每种技术的相关优点和缺点,并考虑了在军事环境中会影响最终效果的作战因素个人做出的避孕选择。案例研究一名19岁的Able Rate加入了皇家海军(RN),并在加入医疗机构时被告知她曾在Microgynon上服役?联合口服避孕药约三年。在这段时间里,她的月经期仍然很短。她从未经历过不良反应,表现出良好的依从性,并且很高兴继续接受这种避孕方案。在接下来的18个月中,她每季度都会与Microgynon?一起接受许多医务人员和民政医生的复查。每次都重新规定。使用了适当的国防医学信息能力计划(DMICP)模板,其中包括体重,吸烟状况,依从性以及相应记录的任何问题或评论。 2010年12月,首次记录了有关长效可逆避孕(LARC)的讨论。患者同意给LARC一些想法,并进行了一个月的复诊。随后,她开始服用孕激素纯药Cerazette? 。咨询医生指出,患者的母亲和祖母均患有脑血管病史,并停止联合口服避孕药。经过两个月的复查,患者报告她对Cerazette感到满意?并希望继续使用这种药物。她的闭经,高度顺从,戒烟,体重和血压稳定。但是,由于供应问题,有人解释说Cerazette?不再是她的可行选择。她没有建立家庭的计划,并热衷于研究其他避孕方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号